Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-Associated diarrhea
Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-Associated diarrhea. J Clin Gastroenterol 2010;44:354-60.
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study
Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014;58:1515-22.
Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: A proposed treatment protocol
Russell G, Kaplan J, Ferraro M, et al. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 2010;126:e239-42.
Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child
Kahn SA, Young S, Rubin DT. Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child. Am J Gastroenterol 2012;107:1930-1.
Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease
Russell GH, Kaplan JL, Youngster I, et al. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:588-92.
Laboratory diagnosis of Clostridium difficile infections: There is light at the end of the colon
Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013;57:1175-81.
US Food and Drug Administration/American Association of Blood Banks. Donor history questionnaire. http://www.fda.gov/biologics bloodvaccines/bloodbloodproducts/approvedproducts/licensedproducts blas/blooddonorscreening/ucm164185.htm. Accessed December 1,2014.
Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection
Zipursky JS, Sidorsky TI, Freedman CA, et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012;55:1652-8.